Viemed Healthcare, Inc. VMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.6%+0.1pp | 57.5%-0.4pp | 57.9%-0.4pp | 58.3%-0.4pp | 58.7%-0.7pp | |
| Operating margin | 8.2%-0.3pp | 8.5%+0.2pp | 8.3%-0.5pp | 8.7%+0.3pp | 8.4%+0.4pp | |
| Net margin | 5.2%-0.3pp | 5.5%+0.2pp | 5.3%-0.5pp | 5.8%+0.5pp | 5.3%+0.3pp | |
| EBITDA margin | 18.5%-0.6pp | 19.1%+0.1pp | 19%-0.6pp | 19.6%+0.2pp | 19.4%+0.1pp | |
| Returns | ||||||
| Return on equity | 10.7%-0.3pp | 10.9%+0.4pp | 10.5%-0.3pp | 10.8%+1.0pp | 9.8%+0.6pp | |
| Return on assets | 7.9%0.0pp | 7.9%+0.6pp | 7.3%-0.7pp | 8%+0.6pp | 7.4%+0.6pp | |
| Return on invested capital | 11.7%-0.5pp | 12.2%+1.3pp | 10.9%-0.8pp | 11.8%+0.7pp | 11.1%— | |
| Efficiency | ||||||
| Asset turnover | 1.5×+0.1× | 1.4×+0.1× | 1.4×0.0× | 1.4×0.0× | 1.4×0.0× | |
| Inventory turnover | 25.1×+0.6× | 24.5×+2.1× | 22.4×-0.5× | 22.9×+1.2× | 21.7×+1.3× | |
| Liquidity | ||||||
| Current ratio | 1.2×0.0× | 1.2×+0.1× | 1.1×-0.4× | 1.5×+0.1× | 1.4×0.0× | |
| Quick ratio | 1.1×0.0× | 1.1×0.0× | 1×-0.4× | 1.4×+0.1× | 1.3×0.0× | |
| Cash ratio | 0.2×-0.1× | 0.3×+0.1× | 0.3×-0.3× | 0.5×+0.3× | 0.3×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×-0.1× | 0.2×+0.1× | 0×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×+0.1× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | 0.1×0.0× | 0×-0.2× | 0.3×+0.6× | -0.3×-0.2× | -0.1×+0.2× | |
| Per Share | ||||||
| Book value per share | $3.55+2.5% | $3.47+5.1% | $3.30-3.0% | $3.40+5.1% | $3.24+0.5% | |
| Valuation | ||||||
| Market capitalization | $448.16M+71.3% | $282.47M+7.3% | $263.36M-3.8% | $273.9M-4.8% | $287.72M-7.9% | |
| Enterprise value | $450.83M+74.6% | $284.92M+2.9% | $276.93M+6.2% | $260.77M-8.3% | $284.32M-5.7% | |
| Price / earnings | 30.1×+8.8× | 18.9×-0.4× | 19.3×-0.2× | 19.6×-3.8× | 23.4×-4.3× | |
| Price / sales | 1.6×+0.4× | 1×0.0× | 1×-0.1× | 1.1×-0.1× | 1.2×-0.2× | |
| Price / book | 3.1×+1.2× | 2×0.0× | 2×0.0× | 2×-0.2× | 2.1×-0.2× | |
| EV / EBITDA | 8.5×+2.8× | 5.5×-0.2× | 5.7×+0.2× | 5.5×-0.8× | 6.3×-0.7× | |
| EV / sales | 1.6×+0.5× | 1.1×0.0× | 1.1×0.0× | 1.1×-0.1× | 1.2×-0.1× | |
| Earnings yield | 3.3%-1.4pp | 5.3%+0.1pp | 5.2%+0.1pp | 5.1%+0.8pp | 4.3%+0.7pp | |
| PEG ratio | 1.4×+0.3× | 0.6×-0.1× | 0.6×+0.2× | 0.4×-0.8× | 1.2×-1.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Viemed Healthcare, Inc.'s profit margins?
- Viemed Healthcare, Inc. (VMD) runs a 57.6% gross margin and a 8.2% operating margin, with a 5.2% net margin.
- Where do Viemed Healthcare, Inc.'s ratios come from?
- Every ratio is computed from Viemed Healthcare, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
